Kasabach Merritt syndrome, first recognized in 1940, is characterized by haemangiomatosis, thrombocytopenia and intravascular coagulation. It is most often seen in children, rarely in adults. The mortality rate is 20-30%. Treatment is by removing the haemangiomatosis and correcting the consumptive coagulopathy. The purpose of this paper is to present a patient with Kasabach Merritt syndrome with haemangiomatosis in the spleen and the liver. A review of the relevant literature is given.
CITATION STYLE
Haahr, V., Jacobsen, E., Bendix, K., Nielsen, J. L., & Peterslund, N. A. (1994). Kasabach-Merritt syndrome. Ugeskrift for Laeger, 156(41), 6011–6014. https://doi.org/10.4264/numa.68.339
Mendeley helps you to discover research relevant for your work.